Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XBI vs GNOM overlap: 18% of top holdings shared

Bottom line

How much do XBI and GNOM overlap?

18% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 6.4% of XBI's assets and 17.7% of GNOM's. They are substantially different portfolios, so owning both adds real diversification.

XBI holds far more positions (161 vs 51), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

XBIGNOM
Weight overlap (top 25)18%
Shared holdings5
Weight in shared holdings6.4%17.7%
Total positions16151
Expense ratio0.35%0.5%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings XBI and GNOM have in common

Holding% of XBI% of GNOMOverlap
Moderna Inc1.41%3.28%1.41%
Twist Bioscience Corp1.41%3.97%1.41%
Praxis Precision Medicines Inc1.29%4.01%1.29%
Natera Inc1.16%4.15%1.16%
Ultragenyx Pharmaceutical Inc1.14%2.25%1.14%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XBI

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Oruka Therapeutics Inc — 1.38%
  4. Kymera Therapeutics Inc — 1.36%
  5. Viking Therapeutics Inc — 1.30%
  6. Erasca Inc — 1.27%
  7. Revolution Medicines Inc — 1.20%
  8. Rhythm Pharmaceuticals Inc — 1.20%
  9. CG oncology Inc — 1.20%
  10. SELLAS Life Sciences Group Inc — 1.19%
  11. Vaxcyte Inc — 1.19%
  12. Dianthus Therapeutics Inc — 1.18%
  13. Cytokinetics Inc — 1.18%
  14. Scholar Rock Holding Corp — 1.16%
  15. Roivant Sciences Ltd — 1.16%

Only in GNOM

  1. Guardant Health, Inc. — 5.59%
  2. Illumina, Inc. — 4.82%
  3. Biomarin Pharmaceutical Inc. — 4.09%
  4. Arrowhead Pharmaceuticals, Inc. — 4.07%
  5. Legend Biotech Corp — 4.05%
  6. Vertex Pharmaceuticals Incorporated — 3.95%
  7. CRISPR Therapeutics AG — 3.85%
  8. Veracyte Inc — 3.64%
  9. Qiagen N.V. — 3.54%
  10. BioNTech SE — 3.41%
  11. Bio-techne Corporation — 3.41%
  12. 10X Genomics Inc — 3.23%
  13. Beam Therapeutics Inc — 3.09%
  14. Bnyrepos — 3.05%
  15. Eli Lilly And Company — 2.32%

Asset mix

Asset typeXBIGNOM
Stocks99.9%99.9%
Cash & short-term funds5.9%—
Repurchase agreements—3.1%
Equity derivatives0.1%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryXBIGNOM
US100.8%99.1%
HK—2.0%
GB—1.8%
IE1.2%—
BM1.2%—
NL1.0%—
CH1.0%—
VG0.5%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do XBI and GNOM overlap?
About 18% by weight. 5 securities appear in both funds' top 25 holdings; they make up 6.4% of XBI's assets and 17.7% of GNOM's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do XBI and GNOM have in common?
The largest shared holdings are Moderna Inc, Twist Bioscience Corp, Praxis Precision Medicines Inc, Natera Inc, Ultragenyx Pharmaceutical Inc.
Should I own both XBI and GNOM?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, XBI or GNOM?
XBI is broader, with 161 positions versus 51 for GNOM. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.